Diagnostics are not exclusively used for the treatment of diseases but also for prediction of diseases. Additionally, it is also used for clinical development of drugs, identify reactions of particular diagnostics to patients, and improving outcomes of patients. Big Market Research reports on diagnostic and biotech industry assists businesses to gain thorough understanding of current and future market status. Additionally, it furnishes an extensive analysis of factors driving and restraining growth of the industry along with opportunities, detailed segmentation, and development trends of the market. Moreover, recent news, standards & regulations, policies, and new findings in the industry are cited. Comprehensive market statistics have been highlighted in the report to aid investors and stakeholders to implement various strategies to consolidate their position and sustain in the market.
No of Reports 3035
The Europe oligonucleotide synthesis market is expected to reach US$ $ 1,270.95 Mn in 2027 from US$ 518.02 Mn in 2018. The market is estimated to grow with a CAGR of 13.7% from 2019-2027. The growth of the oligonucleotide synthesis market is primarily attributed to the partnerships and collaborations undertaken by the market players as well as increasing venture capital investments in pharmaceutic...
The North America oligonucleotide Synthesis market is expected to reach US$ $ 1,541.03 Mn in 2027 from US$ 609.90 Mn in 2018. The market is estimated to grow with a CAGR of 11.2% from 2019-2027. The growth of the oligonucleotide Synthesis market is primarily attributed to the rising investments in the development of pharmaceutical and biotechnology companies. However, the growth of the market is r...
Cancer tissue diagnostics market in Europe is expected to grow from US$ 512.73 Mn in the year 2018 and is expected to reach US$ 830.28 Mn by 2027 growing at a CAGR of 5.8% over the forecast period. The growth of the market is driven by the factors such as increasing number of cancer cases and rising geriatric population. On the other hand, high cost of cancer diagnostics in some of the European co...
The North America hereditary cancer testing market is expected to reach US$ 3,247.37 Mn in 2027 from US$ 1,255.79 Mn in 2018. This market is projected to grow at a growth rate of 11.6% from 2019-2027. The growth of the hereditary cancer testing market is primarily attributed to increasing as increasing prevalence of hereditary cancer and growing awareness about hereditary cancer have been boosting...
Asia Pacific Prenatal and Newborn Genetic Testing Market to 2027 – Regional Analysis and Forecasts by Type, Disease Indication, Technology, and End User The Asia Pacific prenatal and newborn genetic testing market is expected to reach US$ 2,570.37 Mn in 2027 from US$ 878.28 in 2018. The market is estimated to grow with a CAGR of 12.8% from 2019-2027. The key factors responsible for the growth of...
The Asia Pacific western blotting market is expected to reach US$ 210.92 Mn in 2027 from US$ 128.20 Mn in 2018. The market is estimated to grow with a CAGR of 5.9% from 2019-2027. The growth of the western blotting market is primarily attributed to the increasing number of initiatives by private and government bodies. However, systemic risks of genetically modified crops is likely to pose a negati...
The Europe western blotting market is expected to reach US$ 295.78 Mn in 2027 from US$ 196.84 Mn in 2018. The market is estimated to grow with a CAGR of 4.8% from 2019-2027. The growth of the western blotting market is primarily attributed to the increasing innovative technologies in the region. However, nonexistence of skilled professionals is likely to pose a negative impact on the market growth...
The North America western blotting market is expected to reach US$ 404.96 Mn in 2027 from US$ 257.05 Mn in 2018. The market is estimated to grow with a CAGR of 5.4% from 2019-2027. The growth of the western blotting market is primarily attributed to the Investments in proteomic research and rising prevalence of Lyme and HIV. However, alternative technologies for protein detection is likely to pose...
Asia Pacific Prenatal and Newborn Genetic Testing Market to 2027 – Regional Analysis and Forecasts by Type, Disease Indication, Technology, and End User The Asia Pacific prenatal and newborn genetic testing market is expected to reach US$ 2,570.37 Mn in 2027 from US$ 878.28 in 2018. The market is estimated to grow with a CAGR of 12.8% from 2019-2027. The key factors responsible for the growth of...
The Asia Pacific western blotting market is expected to reach US$ 210.92 Mn in 2027 from US$ 128.20 Mn in 2018. The market is estimated to grow with a CAGR of 5.9% from 2019-2027. The growth of the western blotting market is primarily attributed to the increasing number of initiatives by private and government bodies. However, systemic risks of genetically modified crops is likely to pose a negati...
The Europe western blotting market is expected to reach US$ 295.78 Mn in 2027 from US$ 196.84 Mn in 2018. The market is estimated to grow with a CAGR of 4.8% from 2019-2027. The growth of the western blotting market is primarily attributed to the increasing innovative technologies in the region. However, nonexistence of skilled professionals is likely to pose a negative impact on the market growth...
The North America western blotting market is expected to reach US$ 404.96 Mn in 2027 from US$ 257.05 Mn in 2018. The market is estimated to grow with a CAGR of 5.4% from 2019-2027. The growth of the western blotting market is primarily attributed to the Investments in proteomic research and rising prevalence of Lyme and HIV. However, alternative technologies for protein detection is likely to pose...
The North America cancer tissue diagnostics market is expected to reach US$ 1,587.38 Mn in 2027 from US$ 923.79 Mn in 2018. This market is projected to grow at a growth rate of 6.5% from 2019-2027. The growth of the cancer tissue diagnostics market is primarily attributed to growing cancer prevalence in North American region and new product launches & FDA approvals. However, lack of reimbursement ...
The analysts forecast the global glutamine market to exhibit a CAGR of 5.42% during the period 2019-2024. The report covers the present scenario and the growth prospects of the global glutamine for 2019-2024. To calculate the market size, the report considers the glutamine sales volume and revenue. The projections featured in the report have been derived using proven research methodologies and as...
The Asia Pacific next generation sequencing market is expected to reach US$ 5,835.6 Mn in 2025 from US$ 1,203.6 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025. Driving factor such as price reduction in sequencing technology and technological developments in next generation sequencing are likely to promote market growth. Whereas, the restricted threat of genetic and...
The Europe next generation sequencing market is expected to reach US$ 7,685.4 Mn in 2025 from US$ 1,633.4 Mn in 2017. The market is estimated to grow with a CAGR of 21.4% from 2018-2025. The growth of the next generation sequencing market is primarily attributed to the technological advancements in sequencing and an extensive use of genomics for medical applications. However, nonexistence of skill...
The North America next generation sequencing market is expected to reach US$ 10,733.0 Mn in 2025 from US$ 2,378.5 Mn in 2017. The market is estimated to grow with a CAGR of 20.7% from 2018-2025. The growth of the next generation sequencing market is primarily attributed to the declining price of sequencing and increasing prevalence of cancer. However, risks associated with genetic data and high co...
The North America next generation sequencing market is expected to reach US$ 10,733.0 Mn in 2025 from US$ 2,378.5 Mn in 2017. The market is estimated to grow with a CAGR of 20.7% from 2018-2025. The growth of the next generation sequencing market is primarily attributed to the declining price of sequencing and increasing prevalence of cancer. However, risks associated with genetic data and high co...
The Asia Pacific genomics market is expected to reach US$ 7.6 Bn in 2025 from US$ 3.2 Bn in 2017. The market is estimated to grow with a CAGR of 10.6% from 2018-2025. The growth of the genomics market is primarily attributed to the increasing number of start-up companies and medical genetics in developing countries. However, nonexistence of skilled professionals and perception of the people for ge...
The Europe genomics market is expected to reach US$ 10.1 Bn in 2025 from US$ 4.6 Bn in 2017. The market is estimated to grow with a CAGR of 10.6% from 2018-2025. The growth of the genomics market is primarily attributed to the rise in the advancements for genome editing technologies and technological developments in genomics. However, nonexistence of skilled professionals and risks associated with...
The North America genomics market is expected to reach US$ 13.3 Bn in 2025 from US$ 5.9 Bn in 2017. The market is estimated to grow with a CAGR of 11.0% from 2018-2025. The growth of the genomics market is primarily attributed to the growth in investments & funds for genomics and declining cost of sequencing procedures. However, t high cost of equipment used in genomics and limitations in genomics...
The Europe genome editing market is expected to reach US$ 3,421.1 Mn in 2025 from US$ 1,052.9 Mn in 2017. The market is estimated to grow with a CAGR of 16.7% from 2018-2025. The growth of the genome editing market is primarily attributed to the rise in the advancements for genome editing technologies and technological developments in genomics. However, European Court of Justice ruling on genome e...
The Europe genome editing market is expected to reach US$ 3,421.1 Mn in 2025 from US$ 1,052.9 Mn in 2017. The market is estimated to grow with a CAGR of 16.7% from 2018-2025. The growth of the genome editing market is primarily attributed to the rise in the advancements for genome editing technologies and technological developments in genomics. However, European Court of Justice ruling on genome e...
The North America genome editing market is expected to reach US$ 4,148.1 Mn in 2025 from US$ 1,234.5 Mn in 2017. The market is estimated to grow with a CAGR of 17.2% from 2018-2025. The growth of the genome editing market is primarily attributed to the rise in the production of genetically modified crops and rising prevalence of the genetic diseases. However, the stringent regulatory framework and...
The North America Metagenomics market is expected to reach US$ 106.9 Mn in 2027 from US$ 55.2 Mn in 2018. The market is estimated to grow with a CAGR of 8.0% from 2018-2027. The growth of the market is driven by the factors such as increasing investments in the metagenomics and diverse applications of metagenomics, in the North America region. Whereas, high cost associated with metagenomics is lik...
The Europe Metagenomics market is expected to reach US$ 89.7 Mn in 2027 from US$ 48.6 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2018-2027. The growth of the market is driven by the factors such as technological advancements in the metagenomics, growing preference for Metagenomics over traditional methods and wide range metagenomics applications, in the Europe region. Whe...
The Asia pacific Metagenomics market is expected to reach US$ 61.9 Mn in 2027 from US$ 30.6 Mn in 2018. The market is estimated to grow with a CAGR of 8.5% from 2018-2027. The growth of the market is driven by the factors such as increasing demand for genomics, growing demand for metagenomics over traditional methods and various applications of metagenomics, in the Asia pacific region. Whereas, ex...
The North America human microbiome market is expected to reach US$ 446.39 Mn in 2025 from US$ 113.88 in 2017. The market is estimated to grow with a CAGR of 21.5% from 2018-2025. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in human microbiome and next-gene...
The Europe human microbiome market is expected to reach US$ 346.67 Mn in 2025 from US$ 72.34 in 2017. The market is estimated to grow with a CAGR of 22.2% from 2018-2025. The growth of the market is driven by the factors such alarming rise in non-communicable diseases (NCDS), rising efforts in the development of human microbiome based therapies and developments in genomics and sequencing technique...
The Asia Pacific human microbiome market is expected to reach US$ 207.81 Mn in 2025 from US$ 41.73 in 2017. The market is estimated to grow with a CAGR of 22.8% from 2018-2025. The growth of the market is driven by the factors such as rising chronic disease due to change in lifestyle and growing interest in human microbiome treatment approach. Whereas, stringent regulatory environment and lack of ...